Cargando…
The use of β(2)-adrenoreceptor agonists in viral bronchiolitis: scientific rationale beyond evidence-based guidelines
Despite scientific evidence proving that inhaled β(2)-adrenergic receptor (β(2)-AR) agonists can reverse bronchoconstriction in all ages, current guidelines advocate against the use of β(2)-AR bronchodilators in infants with viral bronchiolitis because clinical trials have not demonstrated an overal...
Autores principales: | Nino, Gustavo, Rodríguez-Martínez, Carlos E., Castro-Rodriguez, Jose A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553108/ https://www.ncbi.nlm.nih.gov/pubmed/33083437 http://dx.doi.org/10.1183/23120541.00135-2020 |
Ejemplares similares
-
Scientific Rationale for the Use of Alpha-Adrenergic Agonists and Glucocorticoids in the Therapy of Pediatric Stridor
por: Nino, Gustavo, et al.
Publicado: (2011) -
Indacaterol, A Novel Once Daily Inhaled β2-Adrenoreceptor Agonist
por: Roig, Jorge, et al.
Publicado: (2009) -
Mirabegron – a selective β3-adrenoreceptor agonist for the treatment of overactive bladder
por: Bhide, Alka A, et al.
Publicado: (2012) -
Eosinophils protect pressure overload- and β-adrenoreceptor agonist-induced cardiac hypertrophy
por: Yang, Chongzhe, et al.
Publicado: (2022) -
Clinical Utility of β(3)-Adrenoreceptor Agonists for the Treatment of Overactive Bladder: A Review of the Evidence and Current Recommendations
por: Krhut, Jan, et al.
Publicado: (2022)